Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Treasury Shares (2016 - 2025)

Rocket Pharmaceuticals (RCKT) has disclosed Treasury Shares for 5 consecutive years, with $47000.0 as the latest value for Q2 2023.

  • Quarterly Treasury Shares changed N/A to $47000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $47000.0 through Jun 2023, changed N/A year-over-year, with the annual reading at $47000.0 for FY2022, N/A changed from the prior year.
  • Treasury Shares hit $5.0 million in Q4 2025 for Rocket Pharmaceuticals, down from $5.5 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $5.7 million in Q3 2023 to a low of $2571.0 in Q2 2023.
  • Historically, Treasury Shares has averaged $2.0 million across 5 years, with a median of $1.5 million in 2023.
  • Biggest five-year swings in Treasury Shares: tumbled 92.07% in 2019 and later crashed 77.91% in 2020.
  • Year by year, Treasury Shares stood at $53000.0 in 2019, then soared by 43.4% to $76000.0 in 2020, then crashed by 38.16% to $47000.0 in 2022, then changed by 0.0% to $47000.0 in 2023.
  • Business Quant data shows Treasury Shares for RCKT at $47000.0 in Q2 2023, $47000.0 in Q1 2023, and $47000.0 in Q4 2022.